BIOVIE INC. (BIVI) — Institutional Holders, Q2 2026
42 institutional investment managers reported a BIVI position on SEC Form 13F-HR for the quarter ended June 30, 2026, with a combined reported value of $3.9M. Every filer is listed below, ranked by position value. Put and call option positions are excluded, and a firm filing several lots or share classes is shown once with its total.
BIVI in Q2 2026: what funds did
Funds that filed a 13F for both Q1 2026 and Q2 2026, by what they did with the common stock. Share counts are adjusted for any split between the two quarters; dollar figures are the change in shares at this quarter’s price.
Biggest buyers
- MORGAN STANLEYAdded · +530,250 sh+$1.0M
- RENAISSANCE TECHNOLOGIESAdded · +60,000 sh+$116.4K
- CITADEL ADVISORSAdded · +50,660 sh+$98.3K
- Persistent Asset Partners LtdNew · +14,996 sh+$29.1K
- Cambridge Investment Research AdvisorsNew · +13,816 sh+$26.8K
Biggest sellers
- Diametric CapitalTrimmed · -113,364 sh-$219.9K
- PRELUDE CAPITAL MANAGEMENTTrimmed · -59,480 sh-$115.4K
- PHILADELPHIATrimmed · -25,000 sh-$48.5K
- HRT FINANCIALSold out · -23,482 sh-$45.6K
- GEODE CAPITAL MANAGEMENTTrimmed · -13,451 sh-$26.1K
BIVI 13F holders ranked 1–42 of 42
| # | Institution | Shares | Value | % of portfolio | QoQShares vs Q1 2026 |
|---|---|---|---|---|---|
| 1 | MORGAN STANLEY#1 · 605,471 sh | 605,471 | $1.2M | <0.01% | +704.9% |
| 2 | Diametric Capital#2 · 1,006,636 sh | 1,006,636 | $835.4K | 0.09% | -10.1% |
| 3 | Warberg Asset Management#3 · 613,426 sh | 613,426 | $276.0K | 0.05% | +34.3% |
| 4 | RENAISSANCE TECHNOLOGIES#4 · 127,918 sh | 127,918 | $248.2K | <0.01% | +88.3% |
| 5 | ARMISTICE CAPITAL#5 · 500,000 sh | 500,000 | $225.0K | <0.01% | 0.0% |
| 6 | CITADEL ADVISORS#6 · 95,952 sh | 95,952 | $186.1K | 0.00% | +111.9% |
| 7 | PRELUDE CAPITAL MANAGEMENT#7 · 219,204 sh | 219,204 | $147.2K | 0.01% | -21.3% |
| 8 | VANGUARD CAPITAL MANAGEMENT#8 · 70,906 sh | 70,906 | $137.6K | 0.00% | -15.7% |
| 9 | GEODE CAPITAL MANAGEMENT#9 · 70,752 sh | 70,752 | $137.3K | 0.00% | -16.0% |
| 10 | PHILADELPHIA#10 · 50,010 sh | 50,010 | $97.0K | <0.01% | -33.3% |
| 11 | VANGUARD FIDUCIARY#11 · 37,557 sh | 37,557 | $72.9K | 0.00% | 0.0% |
| 12 | MYDA Advisors#12 · 159,800 sh | 159,800 | $71.9K | 0.01% | -5.4% |
| 13 | JANE STREET GROUP#13 · 35,860 sh | 35,860 | $69.6K | 0.00% | +57.3% |
| 14 | NORTHERN#14 · 21,820 sh | 21,820 | $42.3K | 0.00% | +53.8% |
| 15 | HEIGHTS CAPITAL MANAGEMENT#15 · 90,000 sh | 90,000 | $40.5K | <0.01% | 0.0% |
| 16 | ARMSTRONG ADVISORY GROUP#16 · 65,900 sh | 65,900 | $29.7K | — | 0.0% |
| 17 | Persistent Asset Partners Ltd#17 · 14,996 sh | 14,996 | $29.1K | <0.01% | New |
| 18 | XTX Topco Ltd#18 · 14,228 sh | 14,228 | $27.6K | <0.01% | -33.0% |
| 19 | Cambridge Investment Research Advisors#19 · 13,816 sh | 13,816 | $27.0K | <0.01% | New |
| 20 | Caprock Group#20 · 11,300 sh | 11,300 | $21.9K | <0.01% | New |
| 21 | Allworth Financial#21 · 5,600 sh | 5,600 | $10.9K | 0.00% | 0.0% |
| 22 | TWO SIGMA SECURITIES#22 · 13,884 sh | 13,884 | $6.2K | <0.01% | +24.7% |
| 23 | UBS Group AG#23 · 2,175 sh | 2,175 | $4.2K | 0.00% | New |
| 24 | Tower Research Capital (TRC)#24 · 2,064 sh | 2,064 | $4.0K | <0.01% | -72.6% |
| 25 | PNC FINANCIAL SERVICES GROUP#25 · 1,000 sh | 1,000 | $1.9K | 0.00% | 0.0% |
| 26 | SBI Securities , Ltd.#26 · 867 sh | 867 | $1.7K | — | +275.3% |
| 27 | Integrated Wealth Concepts#27 · 86 sh | 86 | $166.00 | 0.00% | New |
| 28 | Caitong International Asset Management , Ltd#28 · 14 sh | 14 | $27.00 | 0.00% | +366.7% |
| 29 | Tradewinds Capital Management#29 · 10 sh | 10 | $20.00 | — | 0.0% |
| 30 | NewEdge Advisors#30 · 10 sh | 10 | $19.00 | 0.00% | New |
| 31 | WELLS FARGO & COMPANY#31 · 10 sh | 10 | $19.00 | 0.00% | -63.0% |
| 32 | OSAIC#32 · 8 sh | 8 | $15.00 | 0.00% | -85.7% |
| 33 | Financial Perspectives#33 · 6 sh | 6 | $12.00 | 0.00% | 0.0% |
| 34 | JPMORGAN CHASE#34 · 5 sh | 5 | $10.00 | 0.00% | 0.0% |
| 35 | FIFTH THIRD BANCORP#35 · 4 sh | 4 | $8.00 | 0.00% | New |
| 36 | GILL CAPITAL PARTNERS#36 · 4 sh | 4 | $8.00 | — | +100.0% |
| 37 | HARBOUR INVESTMENTS#37 · 3 sh | 3 | $6.00 | 0.00% | 0.0% |
| 38 | ALBION FINANCIAL GROUP#38 · 1 sh | 1 | $2.00 | — | 0.0% |
| 39 | BNP PARIBAS FINANCIAL MARKETS#39 · 1 sh | 1 | $2.00 | 0.00% | -50.0% |
| 40 | FMR#40 · 1 sh | 1 | $2.00 | 0.00% | New |
| 41 | DANSKE BANK A/S#41 · 1 sh | 1 | $2.00 | 0.00% | 0.0% |
| 42 | ROYAL BANK OF CANADA#42 · 200 sh | 200 | $0.00 | 0.00% | -2.4% |
Funds that sold out of BIVI in Q2 2026 (3)
Held BIVI at the end of Q1 2026 and filed a Q2 2026 13F without it. Not in the list above, because they no longer hold it. Largest prior position first.
| Institution | Shares sold | Value in Q1 2026 |
|---|---|---|
| HRT FINANCIAL23,482 sh | 23,482 | $32.0K |
| CITIGROUP3,164 sh | 3,164 | $4.4K |
| Vanguard Global Advisers57 sh | 57 | $80.00 |
Source: Form 13F-HR filings on SEC EDGAR, Q2 2026. Values are as reported by each manager at quarter end. “% of portfolio” is the position’s share of the manager’s total reported 13F value for the same quarter. “New” means the manager filed a 13F for Q1 2026 without this position; a dash means no comparison is available. Where a manager’s own filing is internally inconsistent its value is withheld and it is listed last. 13F data shows reported holdings, not recommendations.